DOI
https://doi.org/10.25772/Z75E-5F60
Defense Date
2012
Document Type
Thesis
Degree Name
Master of Science
Department
Clinical Psychology
First Advisor
Bruce Rybarczyk
Second Advisor
Briana Mezuk
Abstract
Depression and medical condition comorbidity can improve or hinder depression care. Comorbid MD-T2DM is particularly relevant for Black Americans due to increased T2DM risk and less mental health services access. Data from the NSAL was used to examine how co-morbid T2DM/HT and MD affect depression care. Only 19.2% of Black Americans with MD and 23.0% with comorbid MD-T2DM reported adequate treatment. Insurance status explained more variance in depression care than age, sex, and ethnicity. Respondents with MD+T2DM were no more or less likely to receive depression care than those with MD alone. However, respondents with MD+HT were more likely to report adequate treatment (OR=2.09 95% CI[1.20, 3.64]) and anti-depressant use for ≥60 days (OR=2.14 95% CI[1.15, 4.02]). Ethnicity, education and insurance status moderated the effects of HT. Yet guideline-concordant depression care is low among depressed Black Americans, including those with comorbid T2DM.
Rights
© The Author
Is Part Of
VCU University Archives
Is Part Of
VCU Theses and Dissertations
Date of Submission
12-14-2012